Oncology & Cancer SurgeryBreast Cancer #1 ChinaPublic · Grade 3AFounded 1980200+ Active Trials
Fudan University Shanghai Cancer Center China’s #2 Oncology Hospital — The National Standard
Fudan University Shanghai Cancer Center (FUSCC) is ranked #2 for oncology in China and serves as the national reference standard for breast cancer diagnosis and treatment. With over 5,000 cancer surgeries performed annually, 200+ active clinical trials, and multidisciplinary tumour boards that follow NCCN and ESMO international guidelines, FUSCC combines research-level expertise with high surgical volume. China Care conducts a proxy consultation at FUSCC on your behalf before you travel, then provides bilingual coordination throughout your stay.
270 Dongan Road, Xuhui District, Shanghai — accessible from Pudong and Hongqiao airports
Quick Facts
Payment
RMB only — paid directly to hospital
Consultation
In-person only at International Medical Centre
Advance booking
1–2 weeks minimum
Language
English (IMC) + bilingual escort
Type
Dedicated cancer centre · Grade 3A · Fudan University
#2
China oncology ranking
5,000+
Cancer surgeries per year
200+
Active clinical trials
1980
Year established
About the Hospital
The National Standard for Oncological Diagnosis & Treatment
Fudan University Shanghai Cancer Center (FUSCC, 复旦大学附属肿瘤医院) was founded in 1980 as China’s first dedicated cancer research and treatment hospital. Today it is ranked #2 nationally for oncology in the Fudan University Hospital Ranking, holding #1 position in multiple individual cancer specialties — including breast cancer. It is the most intensively benchmarked oncology institution in the country.
FUSCC operates as a fully integrated cancer centre: surgical oncology, medical oncology, radiation therapy, palliative care, and cancer genetics are all housed within a single institution with shared multidisciplinary tumour boards. Every complex case is reviewed by a team that includes surgeons, oncologists, radiologists, and pathologists simultaneously — the approach recommended by NCCN and ESMO guidelines for complex oncology cases.
With over 200 active clinical trials, FUSCC also provides access to investigational agents and novel treatment sequences not available at most hospitals. For patients whose cancer has not responded to standard treatment, or who want access to the latest research protocols alongside established care, FUSCC represents a genuinely compelling alternative to Western oncology centres.
"FUSCC does not just treat cancer — it sets the national standard. When Chinese oncologists debate best practice, FUSCC’s protocols are the reference point."
Why Patients Choose FUSCC
Three reasons international patients choose Fudan Shanghai Cancer Center
National Benchmark Oncology
FUSCC is ranked #2 for oncology in China and #1 for breast cancer specifically. Multidisciplinary tumour boards follow NCCN and ESMO international guidelines. When a Chinese oncologist wants a second opinion on a complex breast, lung, or GI cancer case, FUSCC’s recommendations are considered the reference standard. For international patients, this means accessing China’s most rigorous oncological decision-making framework.
Surgical Volume & Expertise
Over 5,000 cancer surgeries performed annually across all tumour sites. High surgical volume at a cancer-specific hospital produces consistently superior outcomes compared to general hospital cancer departments. Minimally invasive and robotic-assisted surgery is the default approach for suitable cases. Reconstructive surgery following mastectomy is performed by dedicated plastic surgery teams integrated with the oncology programme.
Trial Access & Research Depth
With over 200 active clinical trials, FUSCC provides access to investigational agents that are 2–5 years from standard availability. Trials span immunotherapy combinations, targeted agents, novel chemotherapy sequences, and precision oncology approaches. For patients who have failed standard therapy or who want trial enrolment alongside conventional treatment, FUSCC’s research infrastructure provides options unavailable at most hospitals globally.
Clinical Departments
Cancer Specialties Available to International Patients
FUSCC treats all major cancer types within a fully integrated multidisciplinary framework. Below are the specialties most commonly accessed by international patients through China Care.
National #1
Breast Cancer
China’s #1 ranked breast cancer programme. Breast-conserving surgery, mastectomy, sentinel node biopsy, oncoplastic reconstruction. HER2-targeted therapy, hormone receptor management, CDK4/6 inhibitors. Active trials for metastatic breast cancer. BRCA genetic counselling available.
National #1 BreastHER2 TargetedOncoplastic ReconstructionBRCA Counselling
Primary Focus
Lung Cancer
Complete lung cancer programme from staging to surgery, radiation, targeted therapy, and immunotherapy. VATS lobectomy and segmentectomy for early-stage disease. EGFR, ALK, ROS1, KRAS targeted therapy. PD-1/PD-L1 immunotherapy. SBRT for medically inoperable early-stage disease.
VATS SurgeryEGFR/ALK TargetedImmunotherapySBRT
Also Available
Colorectal & GI Cancer
Colorectal, gastric, oesophageal, and pancreatic cancer. Minimally invasive colectomy and rectal surgery. Neoadjuvant chemoradiation for locally advanced rectal cancer. HIPEC for peritoneal metastases. Multidisciplinary liver tumour board for colorectal liver metastases.
Colorectal SurgeryRectal ChemoradiationHIPEC
Also Available
Radiation Oncology
State-of-the-art radiation therapy including IMRT, VMAT, SBRT, and brachytherapy. Image-guided adaptive radiotherapy for moving targets. Proton therapy available via referral to the Shanghai Proton and Heavy Ion Center. Radiation oncology integrated into all multidisciplinary tumour boards.
IMRT / SBRTBrachytherapyAdaptive Radiotherapy
Also Available
Haematological Malignancies
Lymphoma, leukaemia, and myeloma treatment within a dedicated haematology department. Access to NMPA-approved CAR-T cell therapy protocols. Bone marrow transplantation. Active haematology clinical trials for relapsed/refractory cases.
CAR-T TherapyLymphomaBMT
Access via China Care
Not sure which department?
Submit your records to China Care. We identify the right specialist team at FUSCC, conduct a proxy consultation on your behalf, and confirm suitability before you commit to travelling.
How to Access Treatment at Fudan Shanghai Cancer Center
China Care coordinates the full intake process for international patients, from initial record submission through to on-the-ground support during your stay in Shanghai.
Step 1
Submit Your Records to China Care
Share your pathology report, staging imaging (CT, PET-CT, MRI), genetic testing results where available, and a full treatment history. For breast cancer cases, include hormone receptor status (ER, PR, HER2) and any prior surgery or systemic therapy details. China Care prepares a bilingual case summary for the relevant FUSCC department within 1–2 working days.
records review · 1–2 days
Step 2
China Care Conducts a Proxy Consultation on Your Behalf
China Care attends FUSCC in person and consults directly with the relevant specialist — on your behalf, before you travel. The doctor reviews your case summary, indicates whether treatment is suitable, and gives an initial direction. China Care reports the outcome back to you with voice call interpretation in real time during the consultation.
This service is charged at a fixed fee, which covers hospital registration, the in-person proxy consultation, and real-time voice interpretation. Already in China? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
proxy consultation · fixed fee · results same day
Step 3
Travel to Shanghai for Your In-Person Consultation
Armed with the specialist’s initial direction, you travel to Shanghai for your own in-person consultation at FUSCC. The specialist reviews your case in person, confirms the treatment plan, and issues a formal cost estimate — this step cannot be completed remotely at a public hospital. China Care’s bilingual coordinator accompanies you throughout. For complex or advanced cases, a multidisciplinary tumour board (MDT) discussion may be convened at this stage.
in-person consultation · treatment plan & cost estimate issued
Step 4
Admission & Treatment
China Care coordinates your hospital admission through the International Medical Centre. For inpatient surgical treatment, admission occurs on the agreed date. Outpatient treatment (chemotherapy, radiation) can be managed from accommodation near the hospital. China Care’s coordinator remains available throughout your stay for communication support and logistical assistance.
All treatment fees are paid directly to the hospital in Chinese yuan (RMB). FUSCC does not accept international credit cards for inpatient treatment or surgery. A deposit is required at admission; the balance is settled before or at discharge. China Care does not collect or handle medical payments.
IMC admission · RMB payment direct to hospital
Step 5
Discharge and Follow-Up
Full treatment summary, pathology results, and follow-up recommendations are provided in bilingual form. For patients enrolled in clinical trials, a remote monitoring schedule is established. China Care ensures all documentation is prepared in a format compatible with your home oncologist and arranges any necessary return visit scheduling if continuation of treatment in Shanghai is planned.
bilingual documentation · trial follow-up · post-discharge support
Proxy consultation (fixed fee)Bilingual case coordinationMDT tumour board review200+ active clinical trialsIn-person escort & interpretationRMB payment direct to hospitalBilingual discharge documentsPost-discharge coordination
Before You Travel
What international patients need to know
Payment
RMB only
All fees paid directly to hospital in Chinese yuan. No international credit cards. Deposit required at admission.
Advance booking
1–2 weeks minimum
Walk-in not available for international patients. All appointments booked through China Care before you travel.
Consultation type
In-person only
Public hospital. All specialist consultations take place in person at the IMC. Remote pre-consultation not available.
Language
English + bilingual escort
IMC physicians typically speak functional English. Ward staff: Mandarin. China Care arranges escort for Arabic, Russian, and other languages.
From airport
~40–60 min taxi
From Pudong International Airport to Xuhui District. Hongqiao Airport is closer at ~20–30 min. Metro Line 4 / Line 9 available.
Hospital type
Dedicated cancer centre · Grade 3A
China’s first dedicated cancer hospital. Government-funded. Treatment costs quoted directly by the hospital — zero treatment markup from China Care.
Common Questions
What patients ask about Fudan Shanghai Cancer Center
How is FUSCC ranked #2 in China and what does that ranking mean?
FUSCC is ranked #2 for oncology in the Fudan University Hospital Ranking, which evaluates hospitals based on peer reputation (survey of department heads nationally) and scientific output (research volume and citations). It holds the #1 position in the oncology sub-ranking for multiple consecutive years in categories including breast cancer. The ranking specifically measures oncology performance — FUSCC is not a general hospital with an oncology department but a dedicated cancer centre whose entire identity and measurement is oncological. Being ranked #2 overall means only one institution in all of China (CAMS Cancer Hospital, Beijing) is considered its peer.
Can international patients access clinical trials at FUSCC?
Yes — international patients are eligible to enrol in clinical trials at FUSCC provided they meet the trial’s eligibility criteria. China Care submits your case against the active trial portfolio before you travel, so you have a pre-assessment of likely eligibility. Trials span Phase I, Phase II, and Phase III studies. The experimental drug cost is covered by the trial sponsor. Standard care costs during trial participation are the patient’s responsibility. China Care explains the trial structure and consent process in full before you decide to proceed.
What is FUSCC’s approach to breast cancer treatment?
FUSCC’s breast cancer programme is the most comprehensive in China. Every new breast cancer case is reviewed by a dedicated breast MDT that includes breast surgical oncology, medical oncology, radiation oncology, radiology, and genetics. Treatment follows NCCN guidelines adapted to FUSCC’s internal evidence base. For HER2-positive cases, dual HER2 blockade with trastuzumab and pertuzumab is standard where appropriate. For BRCA1/2 carriers, PARP inhibitor therapy and prophylactic surgery discussions are integrated into the treatment plan. Breast reconstruction is offered simultaneously with mastectomy for appropriate cases.
Should I choose FUSCC or a general hospital like Ruijin for cancer treatment in Shanghai?
For the vast majority of cancer patients, FUSCC is the first choice in Shanghai. Its dedicated cancer focus, #2 national ranking, multidisciplinary tumour boards, and trial access set it apart. Ruijin Hospital is an excellent option when haematological malignancies (CAR-T, BMT) are the primary focus, or when the patient has a complex cancer case that also involves a major non-oncological condition where Ruijin’s broader clinical capacity is an advantage. China Care helps you decide based on your specific diagnosis and overall health picture.
How does payment work at FUSCC?
All treatment fees are paid directly to FUSCC in Chinese yuan (RMB). As a public hospital, FUSCC does not accept international credit cards for inpatient treatment or surgery. A deposit is typically required at admission; the remaining balance is settled before discharge. We advise patients to arrange RMB exchange before arrival. Payment is made directly to the hospital. China Care does not collect or process medical payments on your behalf; your coordination fee is paid to China Care separately and in advance.
What language support is available at FUSCC?
IMC physicians at FUSCC typically speak functional English and are accustomed to consulting with international patients. Ward nursing staff, hospital administration, and pharmacy counters operate in Mandarin Chinese. If your primary language is Arabic, Russian, or another language, China Care arranges a bilingual escort who accompanies you to every consultation, translates medical discussions in real time, and liaises with the clinical team throughout your stay. For oncology cases — where understanding treatment options and consent processes is critical — we strongly recommend escort support for all non-Mandarin speakers.
Get Started
Ready to get your cancer case reviewed at FUSCC?
Submit your records to China Care. We conduct a proxy consultation at FUSCC on your behalf and report back before you commit to travelling.
China Care coordinates your case with Fudan University Shanghai Cancer Center’s International Medical Centre. Treatment costs are quoted directly by the hospital. We never add to or mark up the hospital’s quoted treatment cost.
